Is There a Role for Thromboprophylaxis in Selected Outpatients With COVID-19?
| Errataetall: |
CommentOn: JAMA Intern Med. 2022 Oct 1;182(10):1063-1070. - PMID 35980616 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:183 |
|---|---|
| Enthalten in: |
JAMA internal medicine - 183(2023), 2 vom: 01. Feb., Seite 168-169 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kollias, Anastasios [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anticoagulants |
|---|
| Anmerkungen: |
Date Completed 08.02.2023 Date Revised 28.02.2023 published: Print CommentOn: JAMA Intern Med. 2022 Oct 1;182(10):1063-1070. - PMID 35980616 Citation Status MEDLINE |
|---|
| doi: |
10.1001/jamainternmed.2022.5878 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350462003 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350462003 | ||
| 003 | DE-627 | ||
| 005 | 20231226045045.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jamainternmed.2022.5878 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1168.xml |
| 035 | |a (DE-627)NLM350462003 | ||
| 035 | |a (NLM)36534390 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kollias, Anastasios |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Is There a Role for Thromboprophylaxis in Selected Outpatients With COVID-19? |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.02.2023 | ||
| 500 | |a Date Revised 28.02.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: JAMA Intern Med. 2022 Oct 1;182(10):1063-1070. - PMID 35980616 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Heparin, Low-Molecular-Weight |2 NLM | |
| 700 | 1 | |a Kyriakoulis, Konstantinos G |e verfasserin |4 aut | |
| 700 | 1 | |a Dimakakos, Evangelos |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA internal medicine |d 2013 |g 183(2023), 2 vom: 01. Feb., Seite 168-169 |w (DE-627)NLM220635021 |x 2168-6114 |7 nnns |
| 773 | 1 | 8 | |g volume:183 |g year:2023 |g number:2 |g day:01 |g month:02 |g pages:168-169 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jamainternmed.2022.5878 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 183 |j 2023 |e 2 |b 01 |c 02 |h 168-169 | ||